Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Alnylam Pharmaceuticals (ALNY)
NASDAQ:ALNY
Holding ALNY?
Track your performance easily
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 26, 2024 | Pushkal Garg Cmo & Evp Dev & Med Affairs | xxxxxxxxxxxxx | $485773 |
| Jun 26, 2024 | Yvonne Greenstreet Ceo,director | xxxxxxxxxxxxx | $1917475 |
| Jun 26, 2024 | Fitzgerald Kevin Joseph Cso & Evp, Head Of Research | xxxxxxxxxxxxx | $276731 |
| Jun 26, 2024 | Jeffrey V. Poulton Evp & Cfo | xxxxxxxxxxxxx | $370747 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $3850 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $438397 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $550610 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $992858 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,034,541 | Institution | 9.33% | 2,994,073,455 | |
| 11,130,048 | Institution | 8.63% | 2,769,044,642 | |
| 10,609,427 | Institution | 8.23% | 2,639,519,343 | |
| 4,927,057 | Institution | 3.82% | 1,225,802,511 | |
| 4,184,279 | Institution | 3.24% | 1,041,006,772 | |
| 3,622,535 | Institution | 2.81% | 901,250,483 | |
| 3,424,200 | Institution | 2.65% | 851,906,718 | |
| 2,953,386 | Institution | 2.29% | 734,772,903 | |
| 2,850,341 | Institution | 2.21% | 709,136,337 | |
| 2,429,100 | Institution | 1.88% | 604,335,789 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,130,048 | Institution | 8.63% | 2,769,044,642 | |
| 10,609,427 | Institution | 8.23% | 2,639,519,343 | |
| 4,927,057 | Institution | 3.82% | 1,225,802,511 | |
| 3,424,200 | Institution | 2.65% | 851,906,718 | |
| 2,953,386 | Institution | 2.29% | 734,772,903 | |
| 2,850,341 | Institution | 2.21% | 709,136,337 | |
| 2,429,100 | Institution | 1.88% | 604,335,789 | |
| 2,331,102 | Institution | 1.81% | 579,954,867 | |
| 1,705,722 | Institution | 1.32% | 424,366,576 | |
| 1,524,500 | Institution | 1.18% | 379,280,355 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,056,187 | Institution | 3.14% | 1,081,338,892 | |
| 2,723,739 | Institution | 2.11% | 726,121,580 | |
| 1,906,322 | Institution | 1.48% | 508,206,382 | |
| 1,455,176 | Institution | 1.13% | 387,935,370 | |
| 906,470 | Institution | 0.70% | 241,655,837 | |
| 888,395 | Institution | 0.69% | 221,023,792 | |
| 689,773 | Institution | 0.53% | 161,593,121 | |
| 630,444 | Institution | 0.49% | 156,848,163 | |
| 419,675 | Institution | 0.33% | 111,881,158 | |
| 412,497 | Institution | 0.32% | 102,625,129 |
FAQ
Who Owns Alnylam Pharmaceuticals (ALNY)?
Currently, no data Available
What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by institutional investors?
Currently, no data Available
What percentage of Alnylam Pharmaceuticals (ALNY) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Alnylam Pharmaceuticals (ALNY)?
Vanguard owns the most shares of Alnylam Pharmaceuticals (ALNY).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.